| 1888 PressRelease Home | Sign In | Register | About Us | Sitemap |
|
||||
|
|
|
|||||||||||||||
|
 |
 |
|
|
|||||||||||||||||
StockInterview.com Press Release - Stockinterview.com |
|
28 JUL |
Financial Editor Sees No Short Term Benefit For Australian Uranium Companies; Junior Sector Will ‘End In Tears' |
| FNArena Editor Rudi Filapok-Vandyck reports from Australia for StockInterview.com on the uranium sector 'Down Under.' SARASOTA, Fla., July 28, 2006 (1888pressrelease.com) - FNArena financial news editor Rudi Filapok-Vandyck in a Guest Commentary for o ... |
|
28 JUL |
Sprott Asset Management Researcher Sees ‘Energy Floor’ For Molybdenum Price |
| Toronto-based Sprott Asset Management Research Associate Maria Smirnova told StockInterview.com that the energy sector could help provide a floor to the molybdenum price. SARASOTA, Fla., July 28, 2006 (1888pressrelease.com) - Sprott Asset Management Research Associate Maria Smirnova, who follows molybde ... |
|
14 MAR |
United Therapeutics Ovarian Cancer Drug Closer To Commercialization |
| Leading Canadian scientist gets behind new ovarian cancer drug as United Therapeutics conducts Phase III trials in more than 60 research centers across the U.S. New biotech drug, with a reported benign safety profile, may extend ovarian cancer patient’s life by 22 months. Dr. Lorne Tyrrell, Chief Executive of ViRexx Medical (AMEX: REX; Toronto: VIR), told StockInterview, “This is a study where the drug has been gi ... |
|
|||||||||||||
|
||
|
|
Sitemap|
Press Release Sitemap|
Latest Companies|
Buddies|
PR Guidelines|
Privacy Policy Terms of Use| Contact Us| Affiliate Program |
|
